Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2008
11/26/2008CN101312965A Morpholine type cinnamide compound
11/26/2008CN101312964A 4-oxadiazolyl-piperidine compounds and use thereof
11/26/2008CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
11/26/2008CN101312948A Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436430C Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/25/2008US7456211 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008US7456205 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities
11/25/2008US7456200 Compounds
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456182 Phenylpiperazines
11/25/2008US7456180 Piperazine derivatives and their use as therapeutic agents
11/25/2008US7456176 Benzotriazine inhibitors of kinases
11/25/2008US7456175 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; treatment of obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-propionamide, 1-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-3-propyl-urea
11/25/2008US7456174 5-aminoindole derivatives as H3 inverse agonists
11/25/2008US7456173 Compositions comprising zopiclone derivatives and methods of making and using the same
11/25/2008US7456169 Heterocyclic kinase inhibitors
11/25/2008US7456164 Useful for treatment of H3-related diseases such as neurologic disorders, or inflammatory, respiratory and allergic diseases, disorders and conditions; for example, 4-[4-(1-isopropylpiperidin-4-yloxy)phenyl]tetrahydropyran-4-carbonitrile; well absorbed from gastrointestinal tract, metabolically stable
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/21/2008CA2685967A1 Csf-1r inhibitors, compositions, and methods of use
11/20/2008WO2008141020A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
11/20/2008WO2008140220A1 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
11/20/2008WO2008140198A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008140197A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008140066A2 Pyridone derivatives as p38a mapk inhibitors
11/20/2008WO2008139941A1 Substituted imidazole compound and use thereof
11/20/2008WO2008139288A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
11/20/2008WO2008139161A1 Oxazole tyrosine kinase inhibitors
11/20/2008WO2008139152A1 N-oxide-containing pharmaceutical compounds
11/20/2008WO2008138939A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138917A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
11/20/2008WO2008138871A1 Process for the preparation of valsartan
11/20/2008WO2008138591A2 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
11/20/2008WO2008138516A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008WO2008138448A2 Heterocyclic indazole derivatives
11/20/2008WO2008117079B1 Antimicrobial compounds based upon 4-aminoquinoline
11/20/2008WO2007110418A3 Substituted 5-hetaryl-4-aminopyrimidines
11/20/2008WO2007034445A3 Novel piperazine derivatives as renin inhibitors for cardiovascular events and renal insufficiency
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287667 Nucleic Acid Labeling Compounds
11/20/2008US20080287475 4-(3-Aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of Cancer
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287441 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
11/20/2008US20080287440 Novel Antifungal Triazole Derivatives
11/20/2008US20080287438 Agent for preventing or treating neuropathy
11/20/2008US20080287437 Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
11/20/2008US20080287436 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
11/20/2008US20080287435 Active Ingredient Combinations Having Insecticide and Acaricide Properties
11/20/2008US20080287432 6H-1-Thia-5,6-diaza-as-indacene-2-carboxylic acid [3-(3-trifluoromethyl-phenylcarbamoyl)-phenyl]-amide; treatment of kinase-associated diseases
11/20/2008US20080287431 Heterocyclic Compound and Anti-Malignant-Tumor Agent Containing the Same as Active Ingredient
11/20/2008US20080287430 Furan Compounds Useful As Ep1 Receptor Antagonists
11/20/2008US20080287427 Bicyclic Amides as Kinase Inhibitors
11/20/2008US20080287419 Apoptosis promoters
11/20/2008US20080287409 Phenyl and pyridinyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceutical compositions
11/20/2008US20080287399 Substituted Aminopyridines and Uses Thereof
11/20/2008US20080286231 Novel inhibitors of glutaminyl cyclase
11/20/2008DE102007022565A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives
11/20/2008CA2687162A1 Heterocyclic indazole derivatives
11/20/2008CA2686926A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008CA2686909A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008CA2686766A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008CA2686547A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008CA2686091A1 New compounds
11/20/2008CA2685888A1 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/20/2008CA2684563A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
11/20/2008CA2667447A1 Mapk/erk kinase inhibitors
11/19/2008EP1992625A1 Arylamide pyrimidone compounds
11/19/2008EP1992623A1 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
11/19/2008EP1991542A1 Herbicidal isoxazoline compounds
11/19/2008EP1991540A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991531A1 Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
11/19/2008EP1991530A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991529A1 Substituted arylsulfonamides as antiviral agents
11/19/2008EP1991233A2 Hydroxypiperidine derivatives and uses thereof
11/19/2008EP1931661B1 Isoxazolo derivatives as gaba a alpha5 inverse agonists
11/19/2008EP1797081B1 Benzoxazine compounds derivated from phenolphthalein having flame-retardant properties and a process for their preparation
11/19/2008EP1753727B1 Novel cis-imidazolines
11/19/2008EP1751131B1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
11/19/2008EP1284741B1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
11/19/2008CN101309912A Oxazole compound and pharmaceutical composition
11/19/2008CN101309905A Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
11/19/2008CN101309585A Methods and compositions using pde4 modulators for treatment and management of central nervous system injury
11/19/2008CN101307050A Oxazole substituted dihydro pyrazol multi-heterocyclic ring derivates, preparation method and uses thereof
11/19/2008CN101307049A Alkaloid compounds, method for preparing same and applications as enzyme inhibitors
11/19/2008CN101307046A Tripeptidyl peptidase inhibitors
11/19/2008CN100434428C Furazanobenzimidazoles
11/19/2008CN100434425C 4-quinazolone derivative and its use in anti-tumor medicine
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/18/2008US7452992 Heterocyclic compounds as CCR5 antagonists
11/18/2008US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
11/18/2008US7452906 For therapy of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
11/18/2008US7452903 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
11/18/2008US7452895 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
11/18/2008US7452891 MCH antagonists and their use in the treatment of obesity
11/18/2008US7452890 Substituted pyrazoles
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 647